Skip to content
Study details
Enrolling now

Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia

Milton S. Hershey Medical Center
NCT IDNCT06281756ClinicalTrials.gov data as of Apr 2026
Phase

EARLY_PHASE1

Target enrollment

600

Study length

about 4.2 years

Ages

18+

Locations

3 sites in CO, PA

What this study is about

This trial is testing whether Cognitive Behavioral Therapy for Insomnia (CBT-I) and trazodone, a medication, affect sleep and blood pressure in people with insomnia. The goal is to see if different types of treatments work better for certain kinds of insomnia.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Participate in Cognitive Behavioral Treatment for Insomnia (CBT-I)
  • 2.Placebo
  • 3.Take Trazodone

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug classes

trazodone

Endpoints

Primary: Remission of insomnia symptoms 6 months following completion of CBT-I Or RCT Treatment, Remission of insomnia symptoms following Cognitive Behavioral Therapy for Insomnia (CBT-I), Remission of insomnia symptoms following trazodone/placebo Randomized Controlled Trial (RCT)

Secondary: Home Blood Pressure (HBP) Morning Diastolic Blood Pressure (DBP), Home Blood Pressure (HBP) Morning Systolic Blood Pressure (SBP), Insomnia Severity Index (ISI) Score following CBT-I, Insomnia Severity Index (ISI) Score following RCT